<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cushing&#39;s Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Cushing&#39;s Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Cushing&#39;s Syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0018912" target="_blank">
                        MONDO:0018912
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Endocrine Disorders</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Adrenal Gland Diseases</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Chronic Cortisol Excess</div>
                
                <div class="item-desc">Cushing&#39;s syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        glucocorticoid secreting cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000460" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">glucocorticoid secretion</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome is defined as a prolonged increase in plasma cortisol levels that is not due to a physiological etiology."</div>
                
                
                <div class="evidence-explanation">This review confirms the fundamental pathophysiology of Cushing&#39;s syndrome as prolonged cortisol excess.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypothalamic-Pituitary-Adrenal Axis Dysregulation</div>
                
                <div class="item-desc">In endogenous Cushing&#39;s, the normal negative feedback regulation of cortisol on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH secretion from pituitary or ectopic sources, while ACTH-independent forms involve autonomous adrenal cortisol production bypassing normal regulation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        corticotroph
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002309" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing disease, in which corticotropin excess is produced by a benign pituitary tumor, occurs in approximately 60% to 70% of patients with Cushing syndrome due to endogenous cortisol production."</div>
                
                
                <div class="evidence-explanation">This confirms that ACTH-secreting pituitary tumors are the most common cause of endogenous Cushing&#39;s, representing HPA axis dysregulation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Metabolic Consequences of Hypercortisolism</div>
                
                <div class="item-desc">Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis, protein catabolism in muscle and skin, redistribution of adipose tissue to central deposits, and altered lipid metabolism, leading to the characteristic phenotypic features of the syndrome.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">response to glucocorticoid</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."</div>
                
                
                <div class="evidence-explanation">This confirms the metabolic consequences including hyperglycemia, protein catabolism, and weight gain.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Central Obesity
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001956" target="_blank">
                            HP:0001956
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition in the face, back of the neck, and visceral organs."</div>
                
                
                <div class="evidence-explanation">This confirms central obesity with excess fat in the face, back of neck (buffalo hump), and visceral organs.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Purple Striae
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001065" target="_blank">
                            HP:0001065
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae"</div>
                
                
                <div class="evidence-explanation">This confirms purple striae as a characteristic skin manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Proximal Muscle Weakness
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0003701" target="_blank">
                            HP:0003701
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."</div>
                
                
                <div class="evidence-explanation">Protein catabolism from cortisol excess causes proximal muscle weakness and myopathy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hypertension
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000822" target="_blank">
                            HP:0000822
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition"</div>
                
                
                <div class="evidence-explanation">This confirms hypertension as a characteristic metabolic manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Glucose Intolerance
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001952" target="_blank">
                            HP:0001952
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."</div>
                
                
                <div class="evidence-explanation">Hyperglycemia from cortisol-induced insulin resistance is a key feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Osteoporosis
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000939" target="_blank">
                            HP:0000939
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Easy Bruising
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000978" target="_blank">
                            HP:0000978
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae"</div>
                
                
                <div class="evidence-explanation">Easy bruising is confirmed as a characteristic skin change.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Surgical Resection
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">First-line treatment for most endogenous Cushing&#39;s syndrome: transsphenoidal surgery for pituitary adenomas (Cushing&#39;s disease), adrenalectomy for adrenal tumors, or resection of ectopic ACTH-secreting tumors.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Management of Cushing syndrome begins with surgery to remove the source of excess endogenous cortisol production"</div>
                
                
                <div class="evidence-explanation">Surgery is confirmed as the first-line treatment for endogenous Cushing&#39;s syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Medical Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Steroidogenesis inhibitors (ketoconazole, metyrapone, osilodrostat) or glucocorticoid receptor antagonists (mifepristone) to control hypercortisolism when surgery is not possible or has failed.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"medication that includes adrenal steroidogenesis inhibitors, pituitary-targeted drugs, or glucocorticoid receptor blockers"</div>
                
                
                <div class="evidence-explanation">Multiple medication classes are used for hypercortisolism management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Radiation Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Pituitary radiation (conventional or stereotactic radiosurgery) for persistent or recurrent Cushing&#39;s disease after unsuccessful surgery.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"For patients not responsive to surgery and medication, radiation therapy and bilateral adrenalectomy may be appropriate."</div>
                
                
                <div class="evidence-explanation">Radiation therapy is confirmed as an option for refractory cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Bilateral Adrenalectomy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0001030" target="_blank">
                            MAXO:0001030
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Definitive treatment option for patients with persistent hypercortisolism, resulting in permanent adrenal insufficiency requiring lifelong hormone replacement.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37432427" target="_blank">PMID:37432427</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"For patients not responsive to surgery and medication, radiation therapy and bilateral adrenalectomy may be appropriate."</div>
                
                
                <div class="evidence-explanation">Bilateral adrenalectomy is confirmed as a treatment for refractory cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Cushing&#39;s Syndrome
category: Complex
disease_term:
  preferred_term: Cushing syndrome
  term:
    id: MONDO:0018912
    label: Cushing syndrome
parents:
  - Endocrine Disorders
  - Adrenal Gland Diseases
pathophysiology:
  - name: Chronic Cortisol Excess
    description: &gt;
      Cushing&#39;s syndrome results from prolonged exposure to excess glucocorticoids,
      either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from
      pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production).
      Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular
      effects.
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome is defined as a prolonged increase in plasma cortisol levels that is not due to a physiological etiology.&#34;
        explanation: &#34;This review confirms the fundamental pathophysiology of Cushing&#39;s syndrome as prolonged cortisol excess.&#34;
    biological_processes:
      - preferred_term: glucocorticoid secretion
        term:
          id: GO:0035933
          label: glucocorticoid secretion
    cell_types:
      - preferred_term: glucocorticoid secreting cell
        term:
          id: CL:0000460
          label: glucocorticoid secreting cell
  - name: Hypothalamic-Pituitary-Adrenal Axis Dysregulation
    description: &gt;
      In endogenous Cushing&#39;s, the normal negative feedback regulation of cortisol
      on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH
      secretion from pituitary or ectopic sources, while ACTH-independent forms
      involve autonomous adrenal cortisol production bypassing normal regulation.
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing disease, in which corticotropin excess is produced by a benign pituitary tumor, occurs in approximately 60% to 70% of patients with Cushing syndrome due to endogenous cortisol production.&#34;
        explanation: &#34;This confirms that ACTH-secreting pituitary tumors are the most common cause of endogenous Cushing&#39;s, representing HPA axis dysregulation.&#34;
    cell_types:
      - preferred_term: corticotroph
        term:
          id: CL:0002309
          label: corticotroph
  - name: Metabolic Consequences of Hypercortisolism
    description: &gt;
      Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis,
      protein catabolism in muscle and skin, redistribution of adipose tissue to
      central deposits, and altered lipid metabolism, leading to the characteristic
      phenotypic features of the syndrome.
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.&#34;
        explanation: &#34;This confirms the metabolic consequences including hyperglycemia, protein catabolism, and weight gain.&#34;
    biological_processes:
      - preferred_term: response to glucocorticoid
        term:
          id: GO:0051384
          label: response to glucocorticoid
phenotypes:
  - name: Central Obesity
    description: &gt;
      Preferential fat deposition in the trunk, face (moon facies), and dorsocervical
      area (buffalo hump) with relative sparing of the extremities, characteristic
      of hypercortisolism.
    phenotype_term:
      preferred_term: truncal obesity
      term:
        id: HP:0001956
        label: Truncal obesity
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition in the face, back of the neck, and visceral organs.&#34;
        explanation: &#34;This confirms central obesity with excess fat in the face, back of neck (buffalo hump), and visceral organs.&#34;
  - name: Purple Striae
    description: &gt;
      Wide (greater than 1 cm), violaceous stretch marks, typically on the abdomen,
      thighs, and upper arms, resulting from cortisol-induced collagen breakdown
      and skin thinning.
    phenotype_term:
      preferred_term: striae distensae
      term:
        id: HP:0001065
        label: Striae distensae
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae&#34;
        explanation: &#34;This confirms purple striae as a characteristic skin manifestation.&#34;
  - name: Proximal Muscle Weakness
    description: &gt;
      Progressive weakness and wasting of proximal muscles, particularly of the
      lower extremities and pelvic girdle, due to cortisol-induced protein
      catabolism and myopathy.
    phenotype_term:
      preferred_term: proximal muscle weakness
      term:
        id: HP:0003701
        label: Proximal muscle weakness
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.&#34;
        explanation: &#34;Protein catabolism from cortisol excess causes proximal muscle weakness and myopathy.&#34;
  - name: Hypertension
    description: &gt;
      Elevated blood pressure occurring in the majority of patients, resulting from
      cortisol&#39;s mineralocorticoid effects on sodium retention and vascular reactivity.
    phenotype_term:
      preferred_term: hypertension
      term:
        id: HP:0000822
        label: Hypertension
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition&#34;
        explanation: &#34;This confirms hypertension as a characteristic metabolic manifestation.&#34;
  - name: Glucose Intolerance
    description: &gt;
      Impaired glucose tolerance or overt diabetes mellitus due to cortisol-induced
      insulin resistance and increased hepatic gluconeogenesis.
    phenotype_term:
      preferred_term: glucose intolerance
      term:
        id: HP:0001952
        label: Glucose intolerance
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.&#34;
        explanation: &#34;Hyperglycemia from cortisol-induced insulin resistance is a key feature.&#34;
  - name: Osteoporosis
    description: &gt;
      Decreased bone mineral density and increased fracture risk due to cortisol&#39;s
      inhibitory effects on osteoblast function, calcium absorption, and increased
      bone resorption.
    phenotype_term:
      preferred_term: osteoporosis
      term:
        id: HP:0000939
        label: Osteoporosis
  - name: Easy Bruising
    description: &gt;
      Increased skin fragility and easy bruising resulting from cortisol-induced
      loss of subcutaneous connective tissue and capillary fragility.
    phenotype_term:
      preferred_term: bruising susceptibility
      term:
        id: HP:0000978
        label: Bruising susceptibility
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae&#34;
        explanation: &#34;Easy bruising is confirmed as a characteristic skin change.&#34;
treatments:
  - name: Surgical Resection
    description: &gt;
      First-line treatment for most endogenous Cushing&#39;s syndrome: transsphenoidal
      surgery for pituitary adenomas (Cushing&#39;s disease), adrenalectomy for adrenal
      tumors, or resection of ectopic ACTH-secreting tumors.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;Management of Cushing syndrome begins with surgery to remove the source of excess endogenous cortisol production&#34;
        explanation: &#34;Surgery is confirmed as the first-line treatment for endogenous Cushing&#39;s syndrome.&#34;
  - name: Medical Therapy
    description: &gt;
      Steroidogenesis inhibitors (ketoconazole, metyrapone, osilodrostat) or
      glucocorticoid receptor antagonists (mifepristone) to control hypercortisolism
      when surgery is not possible or has failed.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;medication that includes adrenal steroidogenesis inhibitors, pituitary-targeted drugs, or glucocorticoid receptor blockers&#34;
        explanation: &#34;Multiple medication classes are used for hypercortisolism management.&#34;
  - name: Radiation Therapy
    description: &gt;
      Pituitary radiation (conventional or stereotactic radiosurgery) for persistent
      or recurrent Cushing&#39;s disease after unsuccessful surgery.
    treatment_term:
      preferred_term: radiation therapy
      term:
        id: MAXO:0000014
        label: radiation therapy
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;For patients not responsive to surgery and medication, radiation therapy and bilateral adrenalectomy may be appropriate.&#34;
        explanation: &#34;Radiation therapy is confirmed as an option for refractory cases.&#34;
  - name: Bilateral Adrenalectomy
    description: &gt;
      Definitive treatment option for patients with persistent hypercortisolism,
      resulting in permanent adrenal insufficiency requiring lifelong hormone
      replacement.
    treatment_term:
      preferred_term: adrenalectomy
      term:
        id: MAXO:0001030
        label: adrenalectomy
    evidence:
      - reference: PMID:37432427
        supports: SUPPORT
        snippet: &#34;For patients not responsive to surgery and medication, radiation therapy and bilateral adrenalectomy may be appropriate.&#34;
        explanation: &#34;Bilateral adrenalectomy is confirmed as a treatment for refractory cases.&#34;
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Cushings_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>